-The Hindu The core issues are affordable access to medicines and their rational prescription and use The Medical Council of India (MCI) issued a circular on April 21 drawing attention to clause 1.5 of its regulations regarding the professional conduct of doctors: “Every physician should prescribe drugs with generic names legibly and preferably in capital letters and he/she shall ensure that there is a rational prescription of drugs.” Further, the circular said,...

-Hindustan Times Prominent Indian banks have claimed there is no cash crunch, but fact remains that ATMs run dry during long weekends. The crisis began in November when the Union government pulled 500 and 1000 rupee banknotes from circulation as a part of its crackdown on black money. New Delhi: It has been six months since demonetisation, but, “Is there cash in the ATM?” continues to be the most popular question...

-The Hindu Online media Companies don’t take responsibility for their content, he says Sam Pitroda, regarded as the father of India’s telecom revolution, says that he is deeply concerned with the way social media is being misused globally to propagate lies, hatred and false ideas. In an interview, Mr. Pitroda says that in India also, social media has not been used effectively and technology is not meant to be misapplied. He says...

-PTI RERA Act would bring about a paradigm shift in the way the real estate industry operates Even as the Real Estate Regulatory Act (RERA) comes into effect, delay in issuing notification and non-uniformity of rules across the states may dilute its effective implementation, says the rating agency Icra. The Act would bring about a paradigm shift in the way the real estate industry operates and improve the level of transparency and accountability...

-The Telegraph New Delhi: The World Health Organisation has announced a plan to approve generic versions of two expensive bio-therapeutic anti-cancer molecules in an effort to make them available to low and middle-income countries. It said it would invite manufacturers to submit applications for pre-qualification of biologically similar versions of rituximab, used to treat chronic lymphocytic leukaemia and non-Hodgkin's lymphoma, and trastuzumab, used to treat breast cancer. The pre-qualification process is a mechanism...